Lisa Omoto is a Partner in Faruqi & Faruqi, LLP’s Los Angeles office and focuses her practice on consumer protection litigation.

Prior to joining the firm, Lisa was a litigator at a prominent defense firm where she defended corporations and individuals in a wide variety of complex disputes in federal and state courts.

Lisa graduated from Boston College (B.A., 2010) and Santa Clara University School of Law (J.D., 2014).  She is licensed to practice law in the State of California and is admitted to practice in the United States District Courts for the Eastern, Central, and Northern Districts of California.

Mr. Faruqi is Co-Founder and a Managing Partner of Faruqi & Faruqi, LLP.  Mr. Faruqi oversees all aspects of the firm’s practice areas.  Mr. Faruqi has acted as sole lead or co-lead counsel in many notable class or derivative action cases, such as: In re Olsten Corp. Secs. Litig., C.A. No. 97-CV-5056 (E.D.N.Y.) (recovered $25 million dollars for class members); In re PurchasePro, Inc., Secs. Litig., Master File No. CV-S-01-0483 (D. Nev. 2001) ($24.2 million dollars recovery on behalf of the class in securities fraud action); In re Avatex Corp. S’holders Litig., C.A. No. 16334-NC (Del. Ch. 1999) (established certain new standards for preferred shareholders rights); Dennis v. Pronet, Inc., C.A. No. 96-06509 (Tex. Dist. Ct.) (recovered over $15 million dollars on behalf of shareholders); In re Tellium, Inc. Secs. Litig., C.A. No. 02-CV-5878 (D.N.J.) (class action settlement of $5.5 million); In re Tenet Healthcare Corp. Derivative Litig., Lead Case No. 01098905 (Cal. Sup. Ct. 2002) (achieved a $51.5 million benefit to the corporation in derivative litigation).

Upon graduation from law school, Mr. Faruqi was associated with a large corporate legal department in New York.  In 1988, he became associated with Kaufman Malchman Kirby & Squire, specializing in shareholder litigation, and in 1992, became a member of that firm.  While at Kaufman Malchman Kirby & Squire, Mr. Faruqi served as one of the trial counsel for plaintiff in Gerber v. Computer Assocs. Int’l, Inc., 91-CV-3610 (E.D.N.Y. 1991).  Mr. Faruqi actively participated in cases such as: Colaprico v. Sun Microsystems, No. C-90-20710 (N.D. Cal. 1993) (recovery in excess of $5 million on behalf of the shareholder class); In re Jackpot Secs. Enters., Inc. Secs. Litig., CV-S-89-805 (D. Nev. 1993) (recovery in excess of $3 million on behalf of the shareholder class); In re Int’l Tech. Corp. Secs. Litig., CV 88-440 (C.D. Cal. 1993) (recovery in excess of $13 million on behalf of the shareholder class); and In re Triangle Inds., Inc. S’holders Litig., C.A. No. 10466 (Del. Ch. 1990) (recovery in excess of $70 million).

Mr. Faruqi earned his Bachelor of Science Degree from McGill University, Canada (B.Sc. 1981), his Master of Business Administration from the Schulich School of Business, York University, Canada (MBA 1984) and his law degree from New York Law School (J.D., cum laude, 1987).  Mr. Faruqi was Executive Editor of New York Law School’s Journal of International and Comparative Law.  He is the author of “Letters of Credit: Doubts As To Their Continued Usefulness,” Journal of International and Comparative Law, 1988.  He was awarded the Professor Ernst C. Stiefel Award for Excellence in Comparative, Common and Civil Law by New York Law School in 1987.

Ms. Faruqi is Co-Founder and a Managing Partner of Faruqi & Faruqi, LLP.  Ms. Faruqi is involved in all aspects of the firm’s practice.  Ms. Faruqi has actively participated in numerous cases in federal and state courts which have resulted in significant recoveries for shareholders.

Ms. Faruqi was involved in litigating the successful recovery of $25 million to class members in In re Olsten Corp. Secs. Litig., C.A. No. 97-CV-5056 (E.D.N.Y.).  She helped to establish certain new standards for preferred shareholders in Delaware in In re Avatex Corp. S’holders Litig., C.A. No. 16334-NC (Del. Ch. 1999).  Ms. Faruqi was also lead attorney in In re Mitcham Indus., Inc. Secs. Litig., Master File No. H-98-1244 (S.D. Tex. 1998), where she successfully recovered $3 million on behalf of class members despite the fact that the corporate defendant was on the verge of declaring bankruptcy.

Upon graduation from law school, Ms. Faruqi worked with the Department of Consumer and Corporate Affairs, Bureau of Anti-Trust, the Federal Government of Canada.  In 1987, Ms. Faruqi became associated with Kaufman Malchman Kirby & Squire, specializing in shareholder litigation, where she actively participated in cases such as: In re Triangle Inds., Inc. S’holders Litig., C.A. No. 10466 (Del. Ch. 1990) (recovery in excess of $70 million); Kantor v. Zondervan Corp., C.A. No. 88 C5425 (W.D. Mich. 1989) (recovery of $3.75 million on behalf of shareholders); and In re A.L. Williams Corp. S’holders Litig., C.A. No. 10881 (Del. Ch. 1990) (recovery in excess of $11 million on behalf of shareholders).

Ms. Faruqi graduated from McGill University Law School at the age of twenty-one with two law degrees: Bachelor of Civil Law (B.C.L.) (1980) and a Bachelor of Common Law (L.L.B.) (1981).

Peter Kohn chairs the firm’s pharmaceutical litigation practice and co-chairs its antitrust practice.

Mr. Kohn’s litigation track record is noteworthy.  Publicly-available results include In re Namenda Antitrust Litig., No. 15-7488 (S.D.N.Y.) ($750 million settlement), In re Modafinil Antitrust Litig., No. 06-1797 (E.D. Pa.) ($500 million settlement), In re Suboxone (Buprenorphine Hydrochloride and Naloxone) Antitrust Litig., No. 13-2445 (E.D. Pa.) ($385 million settlement), In re Tricor Direct Purchaser Antitrust Litig., No. 05-340 (D. Del.) ($250 million settlement), In re Buspirone Patent & Antitrust Litig., MDL No. 1410 (S.D.N.Y.) ($220 million settlement), In re Relafen Antitrust Litig., No. 01-12239 (D. Mass.) ($175 million settlement), In re Lidoderm Antitrust Litig., No. 14-2521 (N.D. Cal.) ($166 million settlement), In re Aggrenox Antitrust Litig., No. 14-2516 (D. Conn.) ($146 million settlement), In re Loestrin 24 Fe Antitrust Litig., No. 13-2472 (D.R.I.) ($120 million settlement), In re Cardizem CD Antitrust Litig., No. 99-MD-1278 (E.D. Mich.) ($110 million settlement), In re Solodyn Antitrust Litig., No. 14-10438 (D. Mass) ($76 million settlement), In re Remeron Direct Purchaser Antitrust Litig., No. 03-cv-0085 (D.N.J.) ($75 million settlement), In re Terazosin Hydrochloride Antitrust Litig., No. 99-MDL-1317 (S.D. Fla.) ($72.5 million settlement), and Meijer, Inc. v. Warner-Chilcott, No. 05-2195 (D.D.C.) ($22 million settlement).

He has first-chaired or been appointed to leadership positions in several cases, including In re Pennsylvania Title Ins. Antitrust Litig., No. 08cv1202 (E.D. Pa.), Mylan Pharms., Inc. v. Warner Chilcott, No. 12-cv-3824 (E.D. Pa.), In re Effexor XR Antitrust Litig., No. 11-cv-5479 (D.N.J.), In re Prandin Antitrust Litig., No. 10-12141 (E.D. Mich.), In re Suboxone (Buprenorphine Hydrochloride and Naloxone) Antitrust Litig., No. 13-2445 (E.D. Pa.), In re Loestrin 24 Fe Antitrust Litig., No. 13-2472 (D.R.I.), In re Lidoderm Antitrust Litig., No. 14-2521 (N.D. Cal.), and Value Drug Co. v. Takeda Pharms. USA Inc., No. 21-cv-3500 (E.D. Pa.).

He has been an invited speaker.  He spoke before the American Bar Association’s Section of Antitrust Law’s Spring Meeting in 2010 (on the subject of resale price maintenance), 2015 (on the subject of product “hopping” and FDA risk mitigation abuse), and 2018 (on the subject of reverse-payment patent settlement agreements).  He spoke at HarrisMartin’s Antitrust Pay-for-Delay Litigation Conference in 2014, 2015, and 2017 on the subject of reverse-payment patent settlement agreements.  He spoke in 2012 on the subject of the filed rate doctrine at the American Antitrust Institute.  He has also spoken at ABA “brown bag” lunches on the subject of product hopping cases (2015) and reverse-payment patent settlement agreements (2017).

Earlier in his career, Mr. Kohn defended products liability, toxic and mass tort cases on behalf of insureds and self-insureds at LaBrum & Doak (1992-1994) and prosecuted toxic tort and civil rights actions at Monheit, Monheit, Silverman & Fodera (1994-2000), where he first-chaired several complex and expert-intensive jury trials.  While at the Monheit firm, Mr. Kohn acted as co-liaison counsel for plaintiffs in the lead-based paint poisoning litigation program of the Court of Common Pleas of Philadelphia County, and served as class counsel in three civil rights class actions seeking injunctive relief on behalf of housing authority residents exposed to lead-based paint.  During that time he worked to convince the Pennsylvania Supreme Court that the so-called “pollution exclusion” contained in comprehensive general liability insurance policies did not extend to lead-based paint poisoning.  See Lititz Mut. Ins. Co. v. Steely, 567 Pa. 98, 785 A.2d 975 (Pa. 2001) (reversing id., 746 A.2d 607 (Pa. Super. Ct. 1999)); see also State Auto Ins. Cos. v. Summy, 234 F.3d 131 (3d Cir. 2000).  Working with the state legislature on behalf of his minor clients, Mr. Kohn also successfully advocated for an extension, to civil actions, of the “tender years” hearsay exception of the Pennsylvania Rules of Evidence, which until that time had been limited to criminal actions.

Mr. Kohn has regularly been chosen by his peers as a “SuperLawyer” since 2009.  He is a member of the bars of the Supreme Court of Pennsylvania, the United States Courts of Appeals for the Second, Third, Sixth, Ninth, and Federal Circuits, and the United States District Courts for the Eastern District of Pennsylvania and the Eastern District of Michigan.

He is a 1992 graduate of Temple University Law School (cum laude), and a 1989 graduate of the University of Pennsylvania (B.A., English).  He was  a member of Temple’s trial team and the Temple Law Review.

Mr. Kohn is active in his community.  He has served or is serving on the boards of Philadelphia’s Magic Gardens, Commonwealth Youthchoirs, Settlement Music School (Mary Louise Curtis branch), Philadelphia Boys and Girls Choirs, and Penn’s Mask & Wig Club.

He lives in Center City Philadelphia with his wife and their two sons.

Mr. Clark is Of Counsel for Faruqi and Faruqi, LLP’s Pennsylvania office.  Before joining the firm, Mr. Clark was an associate at Berger & Montague, P.C. where he was significantly involved in prosecuting antitrust class actions on behalf of direct purchasers of brand name drugs and charging pharmaceutical manufacturers with illegally blocking the market entry of less expensive competitors.

Eight of those cases have resulted in substantial settlements totaling over $950 million: In re Cardizem CD Antitrust Litig. settled in November 2002 for $110 million; In re Buspirone Antitrust Litig. settled in April 2003 for $220 million; In re Relafen Antitrust Litig. settled in  February 2004 for $175 million; In re Platinol Antitrust Litig. settled in November 2004 for $50 million; In re Terazosin Antitrust Litig. settled in April 2005 for $75 million; In re Remeron Antitrust Litig. settled in November 2005 for $75 million; In re Ovcon Antitrust Litig. settled in 2009 for $22 million; and In re Tricor Direct Purchaser Antitrust Litig. settled in April 2009 for $250 million.

Mr. Clark was also principally involved in a case alleging a conspiracy among hospitals and the Arizona Hospital and Healthcare Association to depress the compensation of per diem and traveling nurses, Johnson et al. v. Arizona Hospital and Healthcare Association et al., No. CV07-1292 (D. Ariz.).

Mr. Clark was selected as a “Rising Star” by Pennsylvania Super Lawyers and listed as one of the Top Young Lawyers in Pennsylvania in the December 2005 edition of Philadelphia Magazine.  Two cases in which he has been significantly involved have been featured as “Noteworthy Cases” in the NATIONAL LAW JOURNAL articles, “The Plaintiffs’ Hot List” (In re Tricor Antitrust Litig. October 5, 2009 and Johnson v. Arizona Hosp. and Healthcare Ass’n., October 3, 2011).

Mr. Clark graduated cum laude from Appalachian State University in 1994 and from Temple University Beasley School of Law in 1998, where he earned seven “distinguished class performance” awards, an oral advocacy award and a “best paper” award.

Mr. Lukens is a partner in Faruqi & Faruqi, LLP’s Pennsylvania office and Co-Chair of the Firm’s Antitrust Department.

Mr. Lukens was a shareholder at the Philadelphia firm of Hangley Aronchick Segal Pudlin & Schiller, where he represented large retail pharmacy chains as opt-out plaintiffs in numerous lawsuits under the Sherman Act.  Among those lawsuits were In re Brand Name Prescription Drugs Antitrust Litigation (MDL 897, N.D. Ill.), In re Terazosin Hydrochloride Antitrust Litigation (MDL 1317, S.D. Fla.), In re TriCor Direct Purchaser Antitrust Litigation (05-605, D. Del.), In re Nifedipine Antitrust Litigation (MDL1515, D.D.C.), In re OxyContin Antitrust Litigation (04-3719, S.D.N.Y), and In re Chocolate Confectionary Antitrust Litigation (MDL 1935, M.D. Pa.).  While the results in the opt-out cases are confidential, the parallel class actions in those matters which are concluded have resulted in settlements exceeding $1.1 billion.

Earlier in his career, Mr. Lukens concentrated in civil rights litigation at the Philadelphia firm of Schnader, Harrison, Segal & Lewis.  The types of matters that Mr. Lukens handled included antitrust, First Amendment, contracts, and licensing.  Mr. Lukens also worked extensively on several notable pro bono cases including Commonwealth v. Morales, which resulted in a rare reversal on a second post-conviction petition in a capital case in the Pennsylvania Supreme Court.

Mr. Lukens graduated from LaSalle University (B.A. Political Science, cum laude, 1987) and received his law degree from Temple University School of Law (J.D., magna cum laude, 1992) where he was an editor on the Temple Law Review and received several academic awards.  After law school, Mr. Lukens clerked for the Honorable Joseph J. Longobardi, Chief Judge for the United States District Court for the District of Delaware (1992-93).  Mr. Lukens is a member of the bars of the Supreme Court of Pennsylvania (1992-present), the United States Supreme Court (1996-present); the United States District Court for the Eastern District of Pennsylvania (1993-present), the United States Court of Appeals for the Third Circuit (1993-present), and the United States District Court for the District of New Jersey; (1994-present).

Mr. Lukens has several publications, including: Bringing Market Discipline to Pharmaceutical Product Reformulations, 42 Int’l Rev. Intel. Prop. & Comp. Law 698 (September 2011) (co-author with Steve Shadowen and Keith Leffler); Anticompetitive Product Changes in the Pharmaceutical Industry, 41 Rutgers L.J. 1 (2009) (co-author with Steve Shadowen and Keith Leffler); The Prison Litigation Reform Act: Three Strikes and You’re Out of Court — It May Be Effective, But Is It Constitutional?, 70 Temp. L. Rev. 471 (1997); Pennsylvania Strips The Inventory Search Exception From Its Rationale – Commonwealth v. Nace, 64 Temp. L. Rev. 267 (1991).

Innessa M. Huot is a Partner in the firm’s New York office and Chair of the firm’s Employment Practice Group.

Innessa represents workers across the country in both individual and class action lawsuits.  Innessa has litigated cases in both federal and state courts, involving FLSA claims, state wage and hour violations, discrimination and harassment claims, retaliation matters, FMLA and ADA violations, breach of contract disputes, and other employment-related violations.  Innessa has served as lead counsel in numerous cases filed against major businesses and corporations and has successfully recovered millions of dollars on behalf of her clients.

In 2023, Innessa secured the largest verdict in the State of New York for a discrimination case on behalf of an employee terminated because of her disability.  After a two-week trial in federal court, the jury returned a verdict for the plaintiff against her employer in the amount of $1,735,000.00, plus an additional $535,000.00 in prejudgment interest (plus attorneys’ fees and costs).  Ruderman v. Law Office of Yuriy Prakhin, et al., No. 19-CV-2987-CBA-LB, ECF No. 220 (E.D.N.Y. Feb. 24, 2023).

Some of Innessa’s more recent public recoveries include, inter alia:

• $650,000 class and collective action settlement on behalf of law enforcement officers asserting late payment of wages and failure to pay claims.  Pierre v. City of New York, et al. (B&H Foto), No. 20-cv-05116-ALC, ECF No. 516 (S.D.N.Y. Nov. 15, 2024).
• $8,930,186.41 class and collective settlement for Officers asserting late payment of wages and failure to pay claims. Pierre v. City of New York, et al. (TD Bank), No. 20-cv-05116-ALC, ECF No. 499 (S.D.N.Y. Oct. 15, 2024).
• $2.9 million settlement for a collective of maintainers and custodians raising FLSA claims for late payment of wages and overtime. Conte, et al. v. Metro. Transp. Auth., et al., No. 21-cv-02516-VEC (S.D.N.Y. Sept. 14, 2023).
• $7.25 million settlement for a collective of law enforcement officers claiming late payment of wages and failure to pay overtime.  Mercado, et al. v. Metro. Transp. Auth., et al., No. 20-cv-06533-AT (S.D.N.Y. July 5, 2023).
• $5.4 million settlement on behalf of a collective of Sergeants and Lieutenants challenging MTA’s unfair employment and wage practices.  Feliciano, et al. v. Metro. Transp. Auth., et al., No. 18-cv-00026-VSB (S.D.N.Y. May 6, 2020).
• $500,000 settlement for an aggrieved employee asserting FLSA, NYLL, NYCHRL, and NYSHRL claims against her employer.  Goins v. BB&T Sec., LLC, et al., No. 1:20-cv-09891-PGG-JLC (S.D.N.Y. Jan. 6, 2022).
•  $110,000 collective action settlement for workers’ wage and hour claims.  Hall v. J. Caiazzo Plumbing & Heating Corp. et al., No. 1:21-cv-05416-ENV-SJB (E.D.N.Y. Sept. 28, 2021).
• $160,000 settlement for a collective of restaurant workers raising overtime and minimum wage claims.  Molina, et al. v. Huaxcuaxtla Rest. Corp., et al., No. 1:20-cv-02481-RWL (S.D.N.Y. Feb. 25, 2021).
• $425,000 settlement for unpaid wages and overtime on behalf of restaurant workers. Sanchez, et al. v. Stonehouse Rest LLC, et al., No. 1:18-cv-01397-ST (E.D.N.Y. Feb. 4, 2021).
• $135,000 settlement of FLSA and NYLL overtime claims for a collective of workers. Kuznetsov, et al. v. Bravura Glass and Mirror Corp., et al., No. 1:20-cv-00726-LB (E.D.N.Y. Dec. 23, 2020).
• $550,000 settlement for unpaid wages for a class of paramedic and ambulance workers.  Ackerman v. N.Y. Hosp. Med. Ctr. of Queens, No. 702965/2013, NYSCEF Nos. 70 at 1-3; 80 (N.Y. Sup., Queens Cty. June 24, 2020).
• $462,500 class action settlement for wage-and-hour claims raised by restaurant workers. Reeves, et al. v. La Pecora Bianca, Inc, et al., No. 151153/2018 (N.Y. Sup. Ct., June 11, 2020).
• $260,000 settlement of minimum wage and overtime claims.  Porrini v. McRizz, LLC, et al., No. 2:19-cv-03979(ARR)(RML) (E.D.N.Y. Aug. 16, 2022).
• $700,000 settlement for a class of drivers, representing an incredible 100% of their wage damages as well as an additional 75% of their liquidated damages stemming from their wage claims.  Morrell, et al. v. NYC Green Transp. Grp., LLC, et al., No. 1:18-cv-00918-PKC-VMS (E.D.N.Y. May 8, 2019).
• $1.425 million settlement for a class of servers and bartenders challenging unlawful service charge and tip retention practices.  Izzio, et al. v. Century Golf Partners Mgmt., L.P., No. 3:14-cv-03194-M (N.D. Tex. Feb. 13, 2019)
• $9.8 million settlement for unpaid wages and overtime for a class or grocery store employees. Griffin, et al. v. Aldi, Inc., No. 5:16-cv-354 (LEK/ATB) (N.D.N.Y. Nov. 15, 2018)
• $5.6 million class action settlement for 2,917 class members nationwide.  Run Them Sweet, LLC v. CPA Global LTD, et al., No. 1:16-cv-1347-TSE-TCB (E.D. Va. Oct. 6, 2017).
• $51 million class action settlement. Foster, et al. v. L-3 Commc’ns EoTech, Inc., et al., No. 6:15-cv-03519-BCW (W.D. Mo. July 7, 2017).
• $250,000 class action settlement for unpaid overtime and statutory damages.  Strong, et al. v. Safe Auto Ins. Grp., Inc., et al., No. 2:16-cv-765 (S.D. Ohio Aug. 28, 2017).

Innessa has been designated a “Super Lawyer” each year since 2017 and has been selected for inclusion into the America’s Top 100 High Stakes Litigators list.  Innessa is active in multiple bar associations, including the Brooklyn Bar Association’s Young Lawyers Section, American Bar Association’s Section of Labor and Employment, and the National Employment Lawyers Association (NELA).

Innessa earned her J.D., magna cum laude, from Pace Law School and her M.B.A. in Finance, summa cum laude, from Pace Lubin School of Business.  Innessa graduated from Syracuse University with a B.A., summa cum laude, in Political Science and International Relations.

Innessa is licensed to practice law in New York, New Jersey, and Connecticut and is admitted to practice before the United States District Courts for the Southern District, Eastern District, Western District, and Northern District of New York, the District of New Jersey, and the Second Circuit Court of Appeals.

For more information, please visit our Employee Rights website at:
www.EmployeeRightsCounsel.com

 

Katherine M. Lenahan is a Partner in the New York office of Faruqi & Faruqi, LLP and focuses her practice on securities litigation.

Prior to joining Faruqi & Faruqi, Ms. Lenahan practiced securities litigation at Entwistle & Cappucci LLP. Ms. Lenahan gained further experience through internships for the Honorable Sherry Klein Heitler, Administrative Judge for Civil Matters, First Judicial District, and the Kings County District Attorney’s Office.

Ms. Lenahan graduated from Fordham University (B.A., Political Science, magna cum laude, 2009) and Fordham University School of Law (J.D., 2012). While at Fordham Law School, Ms. Lenahan served as an associate editor of the Fordham Intellectual Property, Media and Entertainment Law Journal and was a fellow at the Center on Law and Information Policy.

Ms. Lenahan is licensed to practice law in New York.

James M. Wilson, Jr. is a Partner in Faruqi & Faruqi, LLP’s New York office and Co-Chair of the firm’s Securities Litigation Practice Group.

Prior to joining Faruqi & Faruqi, Mr. Wilson was a partner at Chitwood Harley Harnes, LLP, and a senior associate with Reed Smith, LLP. Mr. Wilson has represented institutional pension funds, corporations and individual investors in courts around the country and obtained significant recoveries, including the following securities class actions: In re ArthroCare Sec. Litig. No. 08-0574 (W.D. Tex.) ($74 million); In re Maxim Integrated Prod. Sec. Litig., No. 08-0832 (N.D.Cal.) ($173 million); In re TyCom Ltd. Sec. Litig., MDL No. 02-1335 (D.N.H.)($79 million); and In re Providian Fin. Corp. Sec. Litig., No. 01-3952 (N.D. Cal.).  Mr. Wilson also has obtained significant relief for shareholders in merger suits, including the following: In re Zoran Corporation Shareholders Litig., No. 6212-VCP (Del. Chancery); and In re The Coca-Cola Company Shareholder Litigation, No. 10-182035 (Fulton County Superior Ct.).

Mr. Wilson has authored numerous articles addressing current developments including the following Expert Commentaries published by Lexis Nexis: The Liability Faced By Financial Institutions From Exposure To Subprime Mortgages; Losses Attributable To Sub-Prime Mortgages; The Supreme Court’s Decision in Stoneridge Investment Partners, LLC v. Scientific-Atlanta, Inc. et al.; Derivative Suite by LLC Members in New York: Tzolis v. Wolff, 10 N.Y.3d 100 (Feb. 14, 2008).

Mr. Wilson obtained his undergraduate degree from Georgia State University (B.A. 1988), his law degree from the University of Georgia (J.D. 1991), and Masters in Tax Law from New York University (LL.M. 1992). He is licensed to practice law in Georgia and New York and is admitted to the United States District Courts for Middle and Northern Districts of Georgia, the Eastern and Southern Districts of New York, and the Courts of Appeals for the Second and Eleventh Circuits.

Timothy J. Peter is a Partner in Faruqi & Faruqi, LLP’s Pennsylvania office and Chair of the firm’s Consumer Protection Litigation Practice Group.

Prior to joining Faruqi & Faruqi, Mr. Peter was an Associate at Cohen Placittella & Roth, P.C. where he was involved in such high profile litigation as: In re Vioxx Products Liability Litigation ($8.25 million recovery for the Commonwealth of Pennsylvania); In re Evergreen Ultra Short Opportunities Fund Securities Litigation ($25 million class action securities settlement in which participating class members will recover over 65% of their losses) and In re: DePuy Orthopaedics, Inc., ASR Hip Implant Products Liability Litigation ($2.5 billion settlement). In addition, Mr. Peter played an important role in the resolution of In re Minerva Group LP v. Mod-Pac Corp., et al., in which defendants increased the price of an insider buyout from $8.20 to $9.25 per share, a significant victory for shareholders. Prior to attending law school, Mr. Peter worked for one of largest financial institutions in the world where he gained significant insight into the inner workings of the financial services industry.

Mr. Peter is a 2009 cum laude graduate of the Michigan State University College of Law, where he served as an associate editor of the Journal of Medicine and Law. He received his undergraduate degree in Economics from the College of Wooster in 2002.

Mr. Peter is admitted to practice in the Commonwealth of Pennsylvania and the U.S. District Court for the Eastern District of Pennsylvania.